Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Universal Health Services
UHS
$10.1B
| $25.8M | 0.02% |
173,600
-34,500
| -17% | -$4.96M |
|
827
Robert Half
RHI
$4.48B
| $25.8M | 0.02% |
463,300
+12,500
| +3% | +$705K |
|
|
ZIXI
828
DELISTED
Zix Corporation
ZIXI
| $25.7M | 0.02% |
3,554,095
-403,705
| -10% | -$3.36M |
|
829
Carriage Services
CSV
$555M
| $25.7M | 0.02% |
1,258,000
-1,600
| -0.1% | -$33.2K |
|
|
AD
830
Array Digital Infrastructure
AD
$3.09B
| $25.7M | 0.02% |
684,162
-159,300
| -19% | -$6.43M |
|
|
SCS
831
DELISTED
Steelcase
SCS
| $25.7M | 0.02% |
1,396,100
+722,500
| +107% | +$12M |
|
832
Central Garden & Pet Co Class A
CENTA
$2.41B
| $25.6M | 0.02% |
1,156,250
-57,875
| -5% | -$1.15M |
|
833
Truist Financial
TFC
$64.7B
| $25.6M | 0.02% |
480,262
-1,395,300
| -74% | -$69.1M |
|
834
Freeport-McMoran
FCX
$93.6B
| $25.6M | 0.02% |
+2,676,471
| New | +$27.5M |
|
835
Willis Lease Finance
WLFC
$1.15B
| $25.6M | 0.02% |
1,385,496
-69,600
| -5% | -$1.4M |
|
|
SOHU
836
Sohu.com
SOHU
$364M
| $25.5M | 0.02% |
2,514,300
+500,200
| +25% | +$5.89M |
|
837
Deluxe
DLX
$1.11B
| $25.5M | 0.02% |
519,105
+46,600
| +10% | +$2.08M |
|
838
Equitable Holdings
EQH
$14.4B
| $25.5M | 0.02% |
1,150,600
+51,200
| +5% | +$1.1M |
|
|
CRCM
839
DELISTED
CARE.COM, INC.
CRCM
| $25.4M | 0.02% |
2,434,100
+47,900
| +2% | +$493K |
|
840
HP
HPQ
$28.6B
| $25.3M | 0.02% |
+1,336,400
| New | +$26.2M |
|
841
Frontline
FRO
$9.02B
| $25.2M | 0.02% |
2,773,688
+908,436
| +49% | +$7.33M |
|
842
Bank of America
BAC
$448B
| $25.2M | 0.02% |
865,066
+367,000
| +74% | +$10.6M |
|
843
The RMR Group
RMR
$346M
| $25.2M | 0.02% |
554,216
+87,100
| +19% | +$4.1M |
|
844
CVS Health
CVS
$121B
| $25.2M | 0.02% |
399,268
+196,615
| +97% | +$11.7M |
|
|
CVA
845
DELISTED
Covanta Holding Corporation
CVA
| $25.1M | 0.02% |
1,454,400
+103,384
| +8% | +$1.78M |
|
846
Credit Acceptance
CACC
$6.05B
| $25.1M | 0.02% |
54,488
+7,485
| +16% | +$3.54M |
|
847
Fortuna Silver Mines
FSM
$3.1B
| $25.1M | 0.02% |
8,133,265
-615,066
| -7% | -$2.24M |
|
848
Webster Financial
WBS
$12.8B
| $25.1M | 0.02% |
535,722
-53,409
| -9% | -$2.53M |
|
849
East-West Bancorp
EWBC
$18.6B
| $25M | 0.02% |
565,233
+60,100
| +12% | +$2.64M |
|
850
EXL Service
EXLS
$5.36B
| $25M | 0.02% |
1,866,550
-399,450
| -18% | -$5.33M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.